CN104087674A - 一种人表皮生长因子受体突变基因检测试剂盒 - Google Patents
一种人表皮生长因子受体突变基因检测试剂盒 Download PDFInfo
- Publication number
- CN104087674A CN104087674A CN201410336176.4A CN201410336176A CN104087674A CN 104087674 A CN104087674 A CN 104087674A CN 201410336176 A CN201410336176 A CN 201410336176A CN 104087674 A CN104087674 A CN 104087674A
- Authority
- CN
- China
- Prior art keywords
- seq
- primer
- probe
- factor receptor
- detection kit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000035772 mutation Effects 0.000 title claims abstract description 46
- 238000001514 detection method Methods 0.000 title claims abstract description 28
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 27
- 101000851181 Homo sapiens Epidermal growth factor receptor Proteins 0.000 title abstract description 5
- 239000000523 sample Substances 0.000 claims abstract description 70
- 238000012217 deletion Methods 0.000 claims abstract description 23
- 230000037430 deletion Effects 0.000 claims abstract description 23
- 238000003780 insertion Methods 0.000 claims abstract description 17
- 230000037431 insertion Effects 0.000 claims abstract description 17
- 102000004190 Enzymes Human genes 0.000 claims abstract description 10
- 108090000790 Enzymes Proteins 0.000 claims abstract description 10
- 239000013642 negative control Substances 0.000 claims abstract description 10
- 102100037111 Uracil-DNA glycosylase Human genes 0.000 claims abstract description 9
- 239000013641 positive control Substances 0.000 claims abstract description 9
- 239000012153 distilled water Substances 0.000 claims abstract description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 6
- 238000006243 chemical reaction Methods 0.000 claims description 35
- 239000000243 solution Substances 0.000 claims description 29
- 108700024394 Exon Proteins 0.000 claims description 21
- KUBDPQJOLOUJRM-UHFFFAOYSA-N 2-(chloromethyl)oxirane;4-[2-(4-hydroxyphenyl)propan-2-yl]phenol Chemical compound ClCC1CO1.C=1C=C(O)C=CC=1C(C)(C)C1=CC=C(O)C=C1 KUBDPQJOLOUJRM-UHFFFAOYSA-N 0.000 claims description 17
- 102000009465 Growth Factor Receptors Human genes 0.000 claims description 17
- 108010009202 Growth Factor Receptors Proteins 0.000 claims description 17
- 230000008859 change Effects 0.000 claims description 17
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 claims description 6
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 claims description 6
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 claims description 6
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 claims description 6
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 claims description 6
- 239000002504 physiological saline solution Substances 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 5
- AHCYMLUZIRLXAA-SHYZEUOFSA-N Deoxyuridine 5'-triphosphate Chemical compound O1[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C[C@@H]1N1C(=O)NC(=O)C=C1 AHCYMLUZIRLXAA-SHYZEUOFSA-N 0.000 claims description 4
- 102100021519 Hemoglobin subunit beta Human genes 0.000 claims description 3
- 108091005904 Hemoglobin subunit beta Proteins 0.000 claims description 3
- 239000013612 plasmid Substances 0.000 claims description 3
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims description 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 claims description 2
- 102000006943 Uracil-DNA Glycosidase Human genes 0.000 claims description 2
- 108010072685 Uracil-DNA Glycosidase Proteins 0.000 claims description 2
- 239000007788 liquid Substances 0.000 abstract description 3
- 238000003752 polymerase chain reaction Methods 0.000 abstract 7
- 239000012295 chemical reaction liquid Substances 0.000 abstract 4
- 102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 description 23
- 108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 description 23
- YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 description 23
- 238000011144 upstream manufacturing Methods 0.000 description 19
- 238000012360 testing method Methods 0.000 description 14
- 102200048928 rs121434568 Human genes 0.000 description 12
- 102200048929 rs121913444 Human genes 0.000 description 12
- 238000000034 method Methods 0.000 description 11
- 102200048955 rs121434569 Human genes 0.000 description 11
- 102200048951 rs121913465 Human genes 0.000 description 10
- 230000003321 amplification Effects 0.000 description 9
- 238000003199 nucleic acid amplification method Methods 0.000 description 9
- 238000010791 quenching Methods 0.000 description 8
- 230000000171 quenching effect Effects 0.000 description 8
- 238000012408 PCR amplification Methods 0.000 description 7
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- 208000002154 non-small cell lung carcinoma Diseases 0.000 description 5
- 238000013016 damping Methods 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 229940121647 egfr inhibitor Drugs 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 239000003471 mutagenic agent Substances 0.000 description 4
- 102200048796 rs28929495 Human genes 0.000 description 4
- 108020004414 DNA Proteins 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000009396 hybridization Methods 0.000 description 3
- 238000003908 quality control method Methods 0.000 description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- 238000007400 DNA extraction Methods 0.000 description 2
- 101150039808 Egfr gene Proteins 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 108700021358 erbB-1 Genes Proteins 0.000 description 2
- 239000007850 fluorescent dye Substances 0.000 description 2
- 230000004907 flux Effects 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 102220052696 rs121913442 Human genes 0.000 description 2
- 102220014422 rs397517094 Human genes 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 238000002626 targeted therapy Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 description 2
- 230000004304 visual acuity Effects 0.000 description 2
- 102000001301 EGF receptor Human genes 0.000 description 1
- 108060006698 EGF receptor Proteins 0.000 description 1
- 206010064571 Gene mutation Diseases 0.000 description 1
- 102000004022 Protein-Tyrosine Kinases Human genes 0.000 description 1
- 108090000412 Protein-Tyrosine Kinases Proteins 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 230000035578 autophosphorylation Effects 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000011242 molecular targeted therapy Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 102200048795 rs121913428 Human genes 0.000 description 1
- 102220052694 rs121913440 Human genes 0.000 description 1
- 102220014448 rs1554350381 Human genes 0.000 description 1
- 102200048979 rs28929495 Human genes 0.000 description 1
- 102220055958 rs727504263 Human genes 0.000 description 1
- 102220052689 rs727504266 Human genes 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000001235 sensitizing effect Effects 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 102000027257 transmembrane receptors Human genes 0.000 description 1
- 108091008578 transmembrane receptors Proteins 0.000 description 1
- 230000004862 vasculogenesis Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6858—Allele-specific amplification
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
突变名称 | 基因突变 | 外显子 | 碱基变化 |
Ex18-m1 | G719A | 18 | 2156G>C |
Ex18-m2 | G719S | 18 | 2155G>A |
Ex18-m3 | G719C | 18 | 2155G>T |
Ex19-m1 | E746_A750del(1) | 19 | 2235_2249del15 |
Ex19-m2 | E746_A750del(2) | 19 | 2236_2250del15 |
Ex19-m3 | L747_P753>S | 19 | 2240_2257del18 |
Ex19-m4 | E746_T751>I | 19 | 2235_2252>AAT(complex) |
Ex19-m5 | E746_T751del | 19 | 2236_2253del18 |
Ex19-m6 | E746_T751>A | 19 | 2237_2251del15 |
Ex19-m7 | E746_S752>A | 19 | 2237_2254del18 |
Ex19-m8 | E746_S752>V | 19 | 2237_2255>T(complex) |
Ex19-m9 | E746_S752>D | 19 | 2238_2255del18 |
Ex19-m10 | L747_A750>P(1) | 19 | 2238_2248>GC(complex) |
Ex19-m11 | L747_T750>Q | 19 | 2238_2252>GCA(complex) |
Ex19-m12 | L747_E749del | 19 | 2239_2247del19 |
Ex19-m13 | L747_T751del | 19 | 2239_2253del15 |
Ex19-m14 | L747_S752del | 19 | 2239_2256del18 |
Ex19-m15 | L747_A750>P(2) | 19 | 2239_2248>C(complex) |
Ex19-m16 | L747_P753>Q | 19 | 2239_2258>CA(complex) |
Ex19-m17 | L747_T751>S | 19 | 2240_2251del12 |
Ex19-m18 | L747_T751del | 19 | 2240_2254del15 |
Ex19-m19 | L747_T751>P | 19 | 2239_2251>C(complex) |
Ex20-m1 | T790M | 20 | 2369C>T |
Ex20-m2 | S768I | 20 | 2303G>T |
Ex20-m3 | H773_V774insH | 20 | 2319_2320insCAC |
Ex20-m4 | D770_N771insG | 20 | 2310_2311insGGT |
Ex20-m5 | V769_D770insASV | 20 | 2307_2308insGCCAGCGTG |
Ex21-m1 | L858R | 21 | 2573T>G |
Ex21-m2 | L861Q | 21 | 2582T>A |
FAM | JOE | ROX | CY5 | |
PCR扩增试剂A | 19外显子缺失 | T790 | L861Q | exon 2 |
PCR扩增试剂B | 20外显子插入 | S768I | L858R | G719X |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410336176.4A CN104087674B (zh) | 2014-07-15 | 2014-07-15 | 一种人表皮生长因子受体突变基因检测试剂盒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410336176.4A CN104087674B (zh) | 2014-07-15 | 2014-07-15 | 一种人表皮生长因子受体突变基因检测试剂盒 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104087674A true CN104087674A (zh) | 2014-10-08 |
CN104087674B CN104087674B (zh) | 2016-02-10 |
Family
ID=51635432
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410336176.4A Active CN104087674B (zh) | 2014-07-15 | 2014-07-15 | 一种人表皮生长因子受体突变基因检测试剂盒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104087674B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105624309A (zh) * | 2016-02-23 | 2016-06-01 | 深圳华大基因研究院 | 检测EGFR和/或K-ras基因突变的引物、探针及试剂盒 |
CN106520994A (zh) * | 2016-12-12 | 2017-03-22 | 厦门飞朔生物技术有限公司 | 一种用于检测egfr基因突变的多重荧光pcr检测试剂盒 |
WO2024000270A1 (zh) * | 2022-06-29 | 2024-01-04 | 京东方科技集团股份有限公司 | 用于检测egfr基因突变的引物探针组合物和试剂盒 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101070538A (zh) * | 2005-03-28 | 2007-11-14 | 裴端卿 | 人表皮生长因子受体突变基因及其用途 |
CN102199657A (zh) * | 2010-03-24 | 2011-09-28 | 吉林大学 | 人表皮生长因子受体外显子19及21突变检测试剂盒 |
CN103282515A (zh) * | 2010-12-22 | 2013-09-04 | 霍夫曼-拉罗奇有限公司 | 用于检测人表皮生长因子受体基因中的突变的方法和组合物 |
-
2014
- 2014-07-15 CN CN201410336176.4A patent/CN104087674B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101070538A (zh) * | 2005-03-28 | 2007-11-14 | 裴端卿 | 人表皮生长因子受体突变基因及其用途 |
CN102199657A (zh) * | 2010-03-24 | 2011-09-28 | 吉林大学 | 人表皮生长因子受体外显子19及21突变检测试剂盒 |
CN103282515A (zh) * | 2010-12-22 | 2013-09-04 | 霍夫曼-拉罗奇有限公司 | 用于检测人表皮生长因子受体基因中的突变的方法和组合物 |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105624309A (zh) * | 2016-02-23 | 2016-06-01 | 深圳华大基因研究院 | 检测EGFR和/或K-ras基因突变的引物、探针及试剂盒 |
CN106520994A (zh) * | 2016-12-12 | 2017-03-22 | 厦门飞朔生物技术有限公司 | 一种用于检测egfr基因突变的多重荧光pcr检测试剂盒 |
CN106520994B (zh) * | 2016-12-12 | 2019-07-23 | 厦门飞朔生物技术有限公司 | 一种用于检测egfr基因突变的多重荧光pcr检测试剂盒 |
WO2024000270A1 (zh) * | 2022-06-29 | 2024-01-04 | 京东方科技集团股份有限公司 | 用于检测egfr基因突变的引物探针组合物和试剂盒 |
Also Published As
Publication number | Publication date |
---|---|
CN104087674B (zh) | 2016-02-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Blassl et al. | Gene expression profiling of single circulating tumor cells in ovarian cancer–Establishment of a multi-marker gene panel | |
CN104946739B (zh) | Egfr基因突变检测试剂盒及其应用 | |
Herreros-Villanueva et al. | KRAS mutations: analytical considerations | |
WO2015180489A1 (zh) | Nras基因突变检测试剂盒 | |
CN104099425A (zh) | 一种用于检测B-raf基因突变的试剂盒 | |
CN103710460A (zh) | 定量检测egfr基因突变的试剂盒及其用途 | |
CN104087674B (zh) | 一种人表皮生长因子受体突变基因检测试剂盒 | |
CN107513578A (zh) | 一种用于肺癌驱动基因及易感基因早筛的核酸质谱检测方法 | |
CN105441562A (zh) | Carl基因缺失、插入突变的检测方法及试剂盒 | |
US7932036B1 (en) | Methods of determining acute myeloid leukemia response to treatment with farnesyltransferase | |
CN104531881A (zh) | 一种人k-ras基因突变荧光pcr检测试剂盒 | |
CN102796811B (zh) | 检测kras突变的试剂及方法 | |
CN103233064B (zh) | 检测表皮生长因子受体19、21外显子突变的引物探针体系、方法及试剂盒 | |
CN107058548A (zh) | c‑kit基因突变检测引物探针及其试剂盒 | |
CN108728538B (zh) | Alk基因融合检测引物、方法及试剂盒 | |
CN108913774B (zh) | 一种c-KIT体细胞突变基因检测试剂盒及其检测方法 | |
Wu et al. | Utilization of cell-transfer technique for molecular testing on hematoxylin-eosin–stained sections: A viable option for small biopsies that lack tumor tissues in Paraffin block | |
CN109536587A (zh) | 一种高效的多重荧光定量pcr试剂盒及其制备方法 | |
CN102899390A (zh) | 小细胞肺癌标志物及其检测 | |
CN106811537A (zh) | 一种检测表皮生长因子受体基因t790m低频突变引物及其应用 | |
CN103305600B (zh) | 使用石蜡包埋切片样品同步检测14种抗肿瘤用药相关基因表达水平的试剂盒及其检测方法 | |
CN102676668B (zh) | 焦磷酸测序法检测egfr基因多态性的试剂盒及方法 | |
CN104073563A (zh) | 一种用于检测alk融合基因的荧光定量pcr方法及检测试剂盒 | |
Uhara et al. | Simple polymerase chain reaction for the detection of mutations and deletions in the epidermal growth factor receptor gene: applications of this method for the diagnosis of non-small-cell lung cancer | |
CN104531889A (zh) | 一种改良的扩增受阻突变检测体系引物及应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160420 Address after: 237300 Anhui Province, Lu'an city Jinzhai County Industrial Park Business Park of modern Chinese parasol tree building A7 Patentee after: ANHUI TONGKE BIOTECHNOLOGY Co.,Ltd. Address before: Suzhou City, Jiangsu Province, Suzhou Industrial Park 215021 Xinghu Street No. 218 BioBAY building A4 Room 405 Patentee before: JIANGSU TONEKER MEDICAL TECHNOLOGY Co.,Ltd. |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Human epidermal growth factor receptor mutation gene detection kit Effective date of registration: 20170919 Granted publication date: 20160210 Pledgee: Anhui Lida finance guarantee Limited by Share Ltd. Pledgor: ANHUI TONGKE BIOTECHNOLOGY Co.,Ltd. Registration number: 2017340000237 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20181010 Granted publication date: 20160210 Pledgee: Anhui Lida finance guarantee Limited by Share Ltd. Pledgor: ANHUI TONGKE BIOTECHNOLOGY Co.,Ltd. Registration number: 2017340000237 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Human epidermal growth factor receptor mutation gene detection kit Effective date of registration: 20181018 Granted publication date: 20160210 Pledgee: Anhui Lida finance guarantee Limited by Share Ltd. Pledgor: ANHUI TONGKE BIOTECHNOLOGY Co.,Ltd. Registration number: 2018340000565 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20191028 Granted publication date: 20160210 Pledgee: Anhui Lida finance guarantee Limited by Share Ltd. Pledgor: ANHUI TONGKE BIOTECHNOLOGY Co.,Ltd. Registration number: 2018340000565 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Human epidermal growth factor receptor mutation gene detection kit Effective date of registration: 20191101 Granted publication date: 20160210 Pledgee: Anhui Lida finance guarantee Limited by Share Ltd. Pledgor: ANHUI TONGKE BIOTECHNOLOGY Co.,Ltd. Registration number: Y2019340000159 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20201209 Granted publication date: 20160210 Pledgee: Anhui Lida finance guarantee Limited by Share Ltd. Pledgor: ANHUI TONGKE BIOTECHNOLOGY Co.,Ltd. Registration number: Y2019340000159 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A human epidermal growth factor receptor mutation gene detection kit Effective date of registration: 20201215 Granted publication date: 20160210 Pledgee: Anhui Lida finance guarantee Limited by Share Ltd. Pledgor: ANHUI TONGKE BIOTECHNOLOGY Co.,Ltd. Registration number: Y2020340000061 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20210923 Granted publication date: 20160210 Pledgee: Anhui Lida finance guarantee Limited by Share Ltd. Pledgor: ANHUI TONGKE BIOTECHNOLOGY Co.,Ltd. Registration number: Y2020340000061 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Human epidermal growth factor receptor mutation gene detection kit Effective date of registration: 20210929 Granted publication date: 20160210 Pledgee: Anhui Lida finance guarantee Limited by Share Ltd. Pledgor: ANHUI TONGKE BIOTECHNOLOGY Co.,Ltd. Registration number: Y2021340000017 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20220929 Granted publication date: 20160210 Pledgee: Anhui Lida finance guarantee Limited by Share Ltd. Pledgor: ANHUI TONGKE BIOTECHNOLOGY Co.,Ltd. Registration number: Y2021340000017 |